Sandbox Reserved 199: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Line 32: Line 32:
===History of NMR Ribonuclease Studies===
===History of NMR Ribonuclease Studies===


In 1957, Martin Saunder et al examined the structure of bovine pancreatic Ribonuclease using 1-Dimensional 1H NMR.
In 1957, Martin Saunder et al examined the structure of bovine pancreatic Ribonuclease using 1-Dimensional 1H NMR.<ref>Saunders, Martin. "The Nuclear magnetic Resonance Spectrum of Ribonuclease" Communications to the Editor. 1448 (1957).</ref>


In 1988, Udgaonkar et al. used 2-dimensional 1H NMR to study bovine pancreatic Ribonuclease and measured protein folding dynamics, which supported the framework model protein folding mechanism.<ref name="Udgaonkar"/>
In 1988, Udgaonkar et al. used 2-dimensional 1H NMR to study bovine pancreatic Ribonuclease and measured protein folding dynamics, which supported the framework model protein folding mechanism.<ref name="Udgaonkar"/>
Line 38: Line 38:
In 1993, Santoro et al. used 3-dimensional 1H NMR to study bovine pancreatic Ribonuclease to compare NMR structures with X-Ray Crystallography structures of RNase A.<ref name="Santoro"/>
In 1993, Santoro et al. used 3-dimensional 1H NMR to study bovine pancreatic Ribonuclease to compare NMR structures with X-Ray Crystallography structures of RNase A.<ref name="Santoro"/>


In 2008, Rico et al. used 3-dimensional 1H NMR to study human pancreatic Ribonuclease.  They looked at active site conformational changes upon substrate binding, and suggested possible biological implications.<ref name="Udgaonkar"/>
In 2008, Rico et al. used 3-dimensional 1H NMR to study human pancreatic Ribonuclease.  They looked at active site conformational changes upon substrate binding, and suggested possible biological implications.<ref name="rico"/>


===Medical Significance===
===Medical Significance===